About Molecular PGx

MolecularPGx is powered by FirmaLab Bio-diagnostics, an accredited CLIA (Clinical Laboratory Improvement Amendments) licensed state-of-the-art laboratory specializing in high-complexity diagnostic testing. Our dedicated team of scientists and experts help healthcare providers utilize the most advanced molecular technology to provide the best possible tools for accurate diagnosis and treatment. Through front-line research, rigorous staff training, and versatile collaboration, FirmaLab provides an unparalleled testing experience to healthcare providers with precision and speed.

What is PGx?

Pharmacogenomics (PGx) testing can identify variations in specific genes related to metabolizing or clearing certain medications from the body. Using this information, doctors can examine your genetic profile to predict whether a medication is likely to help you before you even take it.

 Our 5 PGx panels test for variations of most common drug metabolizers, transporters, and receptors that actively participate in drug metabolism and transportation, processing broad spectrum of drugs used for any disease treatment.

MolecularPGx tests across 36 genes, covering more than 90% of the drugs utilized for patient care. MolecularPGx gene variation panels tests can help physicians and other clinicians identify the most effective drug for each individual patient. This will not only help find which drug may be most effective before treatment starts, but also minimize the risk of adverse reactions and hospitalizations.

PGx testing tests for specific variations in a panel of genes that have been heavily researched and significantly shown to affect both the metabolism and reaction to prescribed medication. Since PGx testing analyzes clinically important genetic variations in one’s DNA, PGx testing improves the accuracy, precision, and clarity in drug selection and administration.

Before PGx testing, caring for patients with prescribed medications followed a “one size fits all” and “trial-and-error” model. Now, physicians and healthcare providers can use information from a simple PGx test to base their treatment on the patient’s genetic makeup and better predict which medications may need dose adjustment, may be less effective, or may lead to an increased risk of side effects.